AmeriPath is one of the leading anatomic pathology practices in the United States. AmeriPath offers a broad range of testing and information services used by physicians in the detection, diagnosis, evaluation and treatment of cancer and other diseases and medical conditions.

The company's extensive diagnostics infrastructure includes over 400 pathologists and doctorate-level scientists providing services in over 40 independent pathology laboratories, more than 200 hospitals, the Center for Advanced Diagnostics (CAD), Dermpath Diagnostics, a division of AmeriPath® and AmeriPath Institute of Urological Pathology and Renal Disease. CAD provides specialized diagnostic testing and information services including Fluorescence In-Situ Hybridization (FISH), Flow Cytometry, DNA Analysis, Polymerase Chain Reaction (PCR), Molecular Genetics, Cytogenetics and HPV Typing. AmeriPath has over 60 board-certified dermatopathologists supporting Dermpath Diagnostics, one of the country's leading providers of dermatopathology services. Additionally, AmeriPath provides clinical trial and research development support to firms involved in developing new cancer and genomic diagnostics and therapeutics.

CAD is a state-of-the-art diagnostic test facility. Its facility in Orlando provides access to sophisticated diagnostic technologies, pathology specialists and education services. CAD provides disease management programs regarding a variety of diseases including leukemia, lymphoma and cancers of the breast, prostate and colon.

Dermpath Diagnostics is a division completely focused on providing exceptional dermatopathology diagnostic services for use by physicians. Dermpath Diagnostics backs our commitment with an unrivaled team of over sixty board-certified dermatopathologists, advanced technology and unparalleled customer support.

The AmeriPath Institute of Urological Pathology and Renal Disease, a national state-of-the-art laboratory, specializes in rendering specific diagnoses on biopsy specimens and in providing second-opinion surgical pathology interpretations from the foremost GU pathology experts in the United States.